We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.4B
AUM Growth
-$79M
Cap. Flow
-$151M
Cap. Flow %
-0.74%
Top 10 Hldgs %
31.15%
Holding
1,305
New
241
Increased
339
Reduced
426
Closed
291

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$166M
2
BNS icon
Scotiabank
BNS
+$139M
3
TD icon
Toronto Dominion Bank
TD
+$129M
4
CVE icon
Cenovus Energy
CVE
+$117M
5
PBA icon
Pembina Pipeline
PBA
+$89.3M

Sector Composition

Rank Sector Weight
1 Financials 27.05%
2 Technology 13%
3 Energy 12.62%
4 Industrials 11.87%
5 Materials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
1301
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-4,807
Closed -$209K
RDS.B
1302
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-150
Closed -$7K
EMKR
1303
DELISTED
Emcore Corp
EMKR
-8,867
Closed -$619K
NTP
1304
DELISTED
Nam Tai Property Inc.
NTP
-38,478
Closed -$388K
BDSI
1305
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-106,371
Closed -$330K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 Portfolio in Review

As of Q1 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,305 positions worth $20.4B, down 0.39% from $20.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2022 filing shows 241 new, 339 increased, 426 reduced and 291 closed positions. Its largest new stake was CVS Health: 264,540 shares worth $26.8M. The largest sale was Cameco, an estimated $85.9M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2022 buy was CVS Health: 264,540 shares worth $26.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Enbridge in Q1 2022, an estimated $166M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2022 reduction was Cameco, cutting an estimated $85.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2022, selling an estimated $21.5M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 31% of its $20.4B portfolio in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 241 new positions and closed 291 in Q1 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 0.39% quarter-over-quarter to $20.4B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.